NCT05925530
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05925530
Title Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) (MDT-BRIDGE)
Acronym MDT-BRIDGE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | ITA | HUN | FRA | ESP | DEU | CZE | CAN | AUT

Facility Status City State Zip Country Details
Research Site The Bronx New York 10467 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Charlottesville Virginia 22908 United States Details
Research Site Vienna 1130 Austria Details
Research Site Vienna 1140 Austria Details
Research Site Kingston Ontario K7L 2V7 Canada Details
Research Site Chicoutimi Quebec G7H 5H6 Canada Details
Research Site Montreal Quebec H4A 3J1 Canada Details
Research Site Brno 625 00 Czechia Details
Research Site Olomouc 77900 Czechia Details
Research Site Prague 12808 Czechia Details
Research Site Prague 150 06 Czechia Details
Research Site La Tronche 38700 France Details
Research Site Marseille 13008 France Details
Research Site Montpellier 34295 France Details
Research Site Mulhouse 68070 France Details
Research Site Paris 75005 France Details
Research Site Pessac 33604 France Details
Research Site Poitiers 86000 France Details
Research Site Toulouse 31059 France Details
Research Site Berlin 13125 Germany Details
Research Site Cologne 51109 Germany Details
Research Site Großhansdorf 22927 Germany Details
Research Site Moers 47441 Germany Details
Research Site Würzburg 97074 Germany Details
Research Site Budapest 1122 Hungary Details
Research Site Törökbálint 2045 Hungary Details
Research Site Bari 70124 Italy Details
Research Site Bologna 40138 Italy Details
Research Site Milan 20141 Italy Details
Research Site Milan 20132 Italy Details
Research Site Milan 20133 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Palermo 90127 Italy Details
Research Site Pavia 27100 Italy Details
Research Site Peschiera del Garda 37019 Italy Details
Research Site Lisbon 1350-352 Portugal Details
Research Site Lisbon 1500-650 Portugal Details
Research Site Barakaldo 48903 Spain Details
Research Site Barcelona 08025 Spain Details
Research Site L'Hospitalet de Llobregat 08908 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28027 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Pamplona 31008 Spain Details
Research Site Valencia 46009 Spain Details
Research Site Zaragoza 50009 Spain Details
Research Site Solna 171 64 Sweden Details
Research Site Uppsala SE-751 85 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field